DelveInsight has launched a new report on “Coccidioidomycosis – Market Insights, Epidemiology, and Market Forecast-2032”.
Some of the key facts of the Coccidioidomycosis Market Report:
Key benefits of the report:
Coccidioidomycosis Overview
Coccidioidomycosis (also known as Valley Fever) is an infection usually caused by inhaling the spores (“seeds”) of either Coccidioides immitis or Coccidioides posadasii fungi. These spores are found in the soil in certain geographic areas (called endemic) and get into the air when the soil is disturbed. Coccidioidomycosis cannot be passed from person-to-person.
There are three forms of Coccidioidomycosis i.e. acute pulmonary coccidioidomycosis, chronic pulmonary coccidioidomycosis, and disseminated coccidioidomycosis. Disseminated coccidioidomycosis, is the most severe form of the disease and occurs in about 1% of all cases, usually in people who have a poor immune system or pregnant women. This form can spread to the nervous system, bones, joints, or skin.
Coccidioidomycosis Market
The dynamics of the Coccidioidomycosis market are anticipated to change in the coming years owing to the expected launch of emerging therapies by companies such as Scynexis, Mycovia Pharmaceuticals, F2G, Amplyx Pharmaceuticals, and others during the study period 2019-2032.
Learn more by requesting for sample @ Coccidioidomycosis Market Landscape
Coccidioidomycosis Pipeline Therapies and Key Companies
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Coccidioidomycosis Patient Share (%) Overview at a Glance
5. Coccidioidomycosis Market Overview at a Glance
6. Coccidioidomycosis Disease Background and Overview
7. Coccidioidomycosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Coccidioidomycosis
9. Coccidioidomycosis Current Treatment and Medical Practices
10. Unmet Needs
11. Coccidioidomycosis Emerging Therapies
12. Coccidioidomycosis Market Outlook
13. Country-Wise Coccidioidomycosis Market Analysis (20198–2032)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Coccidioidomycosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about Coccidioidomycosis Market Outlook 2032
Related Reports:
Coccidioidomycosis Pipeline
Coccidioidomycosis Epidemiology
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: +91-9650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/